Results for tag: "Molecular Farming"

Molecular farming, also known as pharming, is an innovative approach in agriculture that involves the production of pharmaceuticals and industrially relevant proteins in genetically modified plants or cultured plant cells. This biotechnological application utilizes the mechanisms of agriculture to cultivate plants that have been engineered to produce non-native proteins or compounds, such as antibodies, vaccines, and enzymes for medical and industrial purposes. The molecular farming market is a specialized segment that intersects the fields of agriculture, medicine, and biotechnology. It leverages the natural effectiveness and scalability of plant systems for the synthesis of complex biological molecules, which can present an advantage over traditional microbial or animal cell culture production systems in terms of cost-effectiveness, safety, and scalability. Some companies that are active in the molecular farming market include Medicago Inc., which specializes in vaccine development using a unique virus-like particle technology produced in plants; Kentucky BioProcessing, known for its work on tobacco plant-based pharmaceutical production; iBio, Inc., focusing on the development and manufacture of therapeutic proteins; and PlantForm Corporation, which is engaged in developing and producing biosimilar and biobetter antibodies. These companies are at the forefront of harnessing the capabilities of plants to address needs in healthcare and industrial processes. Show Less Read more